Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3483
Gene Symbol: IGFALS
IGFALS
0.030 GeneticVariation phenotype BEFREE Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. 24040091 2013
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.090 Biomarker phenotype BEFREE The data suggest that both LRRK2-PD and GBA-PD are similar to IPD, except for an earlier age at onset and relatively more common non-motor symptoms in GBA-PD patients. 24095219 2014
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.060 Biomarker phenotype BEFREE The data suggest that both LRRK2-PD and GBA-PD are similar to IPD, except for an earlier age at onset and relatively more common non-motor symptoms in GBA-PD patients. 24095219 2014
Entrez Id: 2630
Gene Symbol: GBAP1
GBAP1
0.010 Biomarker phenotype BEFREE The data suggest that both LRRK2-PD and GBA-PD are similar to IPD, except for an earlier age at onset and relatively more common non-motor symptoms in GBA-PD patients. 24095219 2014
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.100 GeneticVariation phenotype BEFREE These data provide an insight into the physiological function of α-SYN in NErgic neuronal cells, which further indicates that the α-SYN mutation may play a causative role in the generation of non-motor symptoms in PD. 24252179 2014
Entrez Id: 2668
Gene Symbol: GDNF
GDNF
0.020 Biomarker phenotype BEFREE Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease. 24312503 2013
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.020 AlteredExpression phenotype BEFREE We describe a novel mouse model of MJD which expresses mutant human ataxin-3 at near endogenous levels and manifests MJD-like motor symptoms that appear gradually and progress over time. 24477711 2014
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.020 GeneticVariation phenotype BEFREE Recent studies report a higher risk of dementia and motor symptoms in females with the fragile X mental retardation 1 premutation (PM-carriers) than has hitherto been appreciated. 24814676 2014
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.090 GeneticVariation phenotype BEFREE In particular, we investigated gender-related differences in motor and non-motor symptoms in the LRRK2 population. 24816003 2014
Entrez Id: 55145
Gene Symbol: THAP1
THAP1
0.010 GeneticVariation phenotype BEFREE The aim of this study was to investigate the prevalence of THAP1 variants in Brazilian patients with idiopathic dystonia and to describe their clinical characteristics including non-motor symptoms. 24976531 2014
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.090 GeneticVariation phenotype BEFREE Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants. 25062988 2015
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.090 GeneticVariation phenotype BEFREE Hyposmia, depression, constipation and excessive daytime sleepiness, were reported to occur before the onset of classical motor symptoms in more than 40% of LRRK2-PD patients in whom these symptoms were present at the time of examination. 25330404 2014
Entrez Id: 729230
Gene Symbol: CCR2
CCR2
0.010 GeneticVariation phenotype BEFREE In addition, several studies have suggested a role for the MCP-1 and CCR2 genotypes in cognitive impairment and depression, which are common non-motor symptoms in PD patients. 25370917 2015
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.060 GeneticVariation phenotype BEFREE This study was undertaken to evaluate progression of motor and non-motor symptoms in sporadic PD patients depending on the mutational GBA status. 25448271 2015
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.100 GeneticVariation phenotype BEFREE The objective of the present study was to determine whether genetic variants of the dopamine transporter type 1-encoding gene (SLC6A3) are associated with differences in the response to treatment of motor symptoms and gait disorders with l-DOPA and methylphenidate (with respect to the demographic, the disease and the treatment parameters and the other genes involved in the dopaminergic neurotransmission). 25805645 2015
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.100 GeneticVariation phenotype BEFREE The associations of hyposmia with SNCA variants and disease phenotypic characteristics including motor symptoms (UPDRS motor score) and other common NMSs (clinical possible RBD-cpRBD, depression and chronic constipation) were analyzed. 25921825 2015
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.100 Biomarker phenotype BEFREE Parkinson's disease, neuropathologically defined by the aggregation of α-synuclein, is characterized by neuropsychiatric symptoms such as depression and anxiety preceding the onset of motor symptoms. 26201615 2015
Entrez Id: 10846
Gene Symbol: PDE10A
PDE10A
0.030 AlteredExpression phenotype BEFREE Our findings demonstrate striatal and pallidal loss of PDE10A expression, which is associated with Parkinson's duration and severity of motor symptoms and complications. 26210536 2015
Entrez Id: 8867
Gene Symbol: SYNJ1
SYNJ1
0.010 Biomarker phenotype BEFREE Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism. 26725142 2016
Entrez Id: 3897
Gene Symbol: L1CAM
L1CAM
0.010 GeneticVariation phenotype BEFREE Hundreds of L1CAM gene mutations have been shown to be associated with congenital hydrocephalus, severe intellectual disability, aphasia, and motor symptoms. 27001749 2016
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.060 GeneticVariation phenotype BEFREE A higher prevalence and increased severity of motor and non-motor symptoms is observed in PD patients harboring mutant GBA1 alleles, suggesting a link between the gene or gene product and disease development. 27126635 2016
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.010 GeneticVariation phenotype BEFREE Multivariate regression analysis revealed that DRD3 rs6280" genes_norm="1814">p.Ser9Gly (rs6280) heterozygous variant CT (OR = 2.22, 95% CI: 1.03-4.86, p = 0.041), higher daily Levodopa equivalent doses (LED) of drugs (for 100 mg LED, OR = 1.14, 95% CI: 1.01-1.29, p = 0.041), current dopamine agonist but not Levodopa use (OR = 2.16, 95% CI: 1.03-4.55, p = 0.042) and age of onset of motor symptoms under 50 years (OR 2.09, 95% CI: 1.05-4.18, p = 0.035) were independently associated with ICD. 27325396 2016
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.100 Biomarker phenotype BEFREE Our results from the SOD1 model suggest that dendritic and dendritic spine changes foreshadow and underpin the neuromotor phenotypes present in ALS and may contribute to the varied cognitive, executive function and extra-motor symptoms commonly seen in ALS patients. 27488828 2016
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.060 GeneticVariation phenotype BEFREE GBA variants predict a more rapid progression of cognitive dysfunction and motor symptoms in patients with PD, with a greater effect on PIGD than tremor. 27571329 2016
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.100 Biomarker phenotype BEFREE DAT availability was reduced bilaterally, most distinctly on the side contralateral to the main motor symptoms. 27572945 2017